STOCK TITAN

[8-K] Viemed Healthcare, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

NuScale Power (SMR) Form 4: Chief Operating Officer Carl M. Fisher reported two insider transactions surrounding the 8/04/25 vesting of previously granted RSUs. On 8/04/25 he converted 42,625 restricted stock units to Class A common shares at a $0 exercise price (Code M). On 8/05/25 he sold 18,206 shares at $44.386 in a “sell-to-cover” trade to meet tax-withholding obligations (Code S).

Following these moves Fisher owns 90,864 Class A shares directly and retains 42,625 RSUs that continue to vest per the original 2023 award schedule. Net of the tax sale, his direct stake increased by 24,419 shares, suggesting ongoing alignment with shareholder interests. Because the sale was expressly for taxes and the majority of vested shares were kept, the transaction appears routine and is unlikely to exert meaningful pressure on SMR’s share float or signal a strategic shift.

NuScale Power (SMR) Modulo 4: Il Chief Operating Officer Carl M. Fisher ha riportato due operazioni insider legate alla maturazione degli RSU concessi in precedenza il 04/08/25. In tale data ha convertito 42.625 unità di azioni vincolate in azioni ordinarie di Classe A a un prezzo di esercizio di $0 (Codice M). Il 05/08/25 ha venduto 18.206 azioni a $44,386 in un’operazione di “sell-to-cover” per coprire obblighi fiscali (Codice S).

Dopo queste operazioni, Fisher possiede direttamente 90.864 azioni di Classe A e mantiene 42.625 RSU che continueranno a maturare secondo il programma originario del premio 2023. Al netto della vendita per tasse, la sua quota diretta è aumentata di 24.419 azioni, indicando un continuo allineamento con gli interessi degli azionisti. Poiché la vendita è stata effettuata esclusivamente per coprire le tasse e la maggior parte delle azioni maturate è stata mantenuta, l’operazione appare di routine e improbabile che eserciti una pressione significativa sul flottante di SMR o segnali un cambiamento strategico.

NuScale Power (SMR) Formulario 4: El Director de Operaciones Carl M. Fisher reportó dos transacciones internas relacionadas con la consolidación de RSU previamente otorgadas el 04/08/25. En esa fecha, convirtió 42,625 unidades de acciones restringidas en acciones ordinarias Clase A a un precio de ejercicio de $0 (Código M). El 05/08/25 vendió 18,206 acciones a $44.386 en una operación “sell-to-cover” para cubrir obligaciones fiscales (Código S).

Tras estas acciones, Fisher posee directamente 90,864 acciones Clase A y conserva 42,625 RSU que continúan consolidándose según el calendario original de 2023. Después de descontar la venta por impuestos, su participación directa aumentó en 24,419 acciones, lo que sugiere una alineación continua con los intereses de los accionistas. Dado que la venta fue exclusivamente para impuestos y que la mayoría de las acciones consolidadas se mantuvieron, la transacción parece rutinaria y no es probable que ejerza presión significativa sobre el flotante de SMR ni indique un cambio estratégico.

NuScale Power (SMR) 4호 서식: 최고운영책임자 Carl M. Fisher는 2025년 8월 4일에 이전에 부여된 RSU가 베스팅된 것과 관련된 내부자 거래 두 건을 보고했습니다. 8월 4일에 그는 42,625개의 제한 주식 단위(RSU)를 행사 가격 $0로 클래스 A 보통주로 전환했습니다(코드 M). 8월 5일에는 세금 원천징수 의무를 충족하기 위해 18,206주를 주당 $44.386에 매도하는 'sell-to-cover' 거래를 진행했습니다(코드 S).

이 거래 이후 Fisher는 직접 90,864주의 클래스 A 주식을 보유하고 있으며, 원래 2023년 수여 일정에 따라 계속 베스팅되는 42,625개의 RSU를 보유하고 있습니다. 세금 매도를 제외하면 그의 직접 지분은 24,419주 증가하여 주주 이익과의 지속적인 정렬을 시사합니다. 매도는 명백히 세금 납부를 위한 것이고 대부분의 베스팅 주식을 유지했기 때문에 이 거래는 일상적이며 SMR의 유통 주식 수에 큰 영향을 미치거나 전략적 변화 신호로 작용할 가능성은 낮아 보입니다.

NuScale Power (SMR) Formulaire 4 : Le directeur des opérations Carl M. Fisher a rapporté deux transactions d’initiés liées à la levée des RSU précédemment attribuées au 04/08/25. Ce jour-là, il a converti 42 625 unités d’actions restreintes en actions ordinaires de classe A à un prix d’exercice de 0 $ (Code M). Le 05/08/25, il a vendu 18 206 actions à 44,386 $ dans une opération de « sell-to-cover » pour couvrir ses obligations fiscales (Code S).

Après ces opérations, Fisher possède directement 90 864 actions de classe A et conserve 42 625 RSU qui continuent de se libérer selon le calendrier initial de la récompense 2023. Net de la vente pour impôts, sa participation directe a augmenté de 24 419 actions, ce qui suggère un alignement continu avec les intérêts des actionnaires. Comme la vente a été effectuée expressément pour les impôts et que la majorité des actions libérées ont été conservées, la transaction semble routinière et ne devrait pas exercer de pression significative sur le flottant de SMR ni indiquer un changement stratégique.

NuScale Power (SMR) Formular 4: Chief Operating Officer Carl M. Fisher meldete zwei Insider-Transaktionen im Zusammenhang mit der Vesting von zuvor gewährten RSUs am 04.08.25. An diesem Tag wandelte er 42.625 Restricted Stock Units in Class A Stammaktien zu einem Ausübungspreis von 0 $ um (Code M). Am 05.08.25 verkaufte er 18.206 Aktien zu 44,386 $ in einem „Sell-to-Cover“-Geschäft, um steuerliche Verpflichtungen zu erfüllen (Code S).

Nach diesen Transaktionen besitzt Fisher direkt 90.864 Class A Aktien und hält weiterhin 42.625 RSUs, die gemäß dem ursprünglichen Auszeichnungsplan von 2023 weiter vesten. Abzüglich des Steuerverkaufs stieg sein direkter Anteil um 24.419 Aktien, was auf eine fortlaufende Ausrichtung an den Interessen der Aktionäre hinweist. Da der Verkauf ausdrücklich zur Steuerzahlung erfolgte und der Großteil der vested Aktien behalten wurde, erscheint die Transaktion routinemäßig und wird wahrscheinlich keinen nennenswerten Druck auf den Streubesitz von SMR ausüben oder eine strategische Veränderung signalisieren.

Positive
  • Net increase of 24,419 shares to the COO’s direct holdings, implying greater insider alignment.
  • Sale was tax-related, reducing concern of discretionary profit-taking.
Negative
  • 18,206 shares sold could still be viewed by some investors as insider selling, even if tax-motivated.

Insights

TL;DR: Routine RSU vesting; minor net share gain; negligible impact on valuation.

The filing shows a standard equity-compensation event. Fisher exercised 42.6k RSUs and sold 18.2k shares only to cover taxes, retaining roughly 57% of the vested stock. His new direct ownership of 90.9k shares plus 42.6k unvested RSUs increases insider alignment but is insignificant versus NuScale’s overall float, so market impact should be minimal. No red flags such as discretionary sales, option re-pricing or unusual timing are present. Overall, the disclosure is neutral from a valuation and governance standpoint.

NuScale Power (SMR) Modulo 4: Il Chief Operating Officer Carl M. Fisher ha riportato due operazioni insider legate alla maturazione degli RSU concessi in precedenza il 04/08/25. In tale data ha convertito 42.625 unità di azioni vincolate in azioni ordinarie di Classe A a un prezzo di esercizio di $0 (Codice M). Il 05/08/25 ha venduto 18.206 azioni a $44,386 in un’operazione di “sell-to-cover” per coprire obblighi fiscali (Codice S).

Dopo queste operazioni, Fisher possiede direttamente 90.864 azioni di Classe A e mantiene 42.625 RSU che continueranno a maturare secondo il programma originario del premio 2023. Al netto della vendita per tasse, la sua quota diretta è aumentata di 24.419 azioni, indicando un continuo allineamento con gli interessi degli azionisti. Poiché la vendita è stata effettuata esclusivamente per coprire le tasse e la maggior parte delle azioni maturate è stata mantenuta, l’operazione appare di routine e improbabile che eserciti una pressione significativa sul flottante di SMR o segnali un cambiamento strategico.

NuScale Power (SMR) Formulario 4: El Director de Operaciones Carl M. Fisher reportó dos transacciones internas relacionadas con la consolidación de RSU previamente otorgadas el 04/08/25. En esa fecha, convirtió 42,625 unidades de acciones restringidas en acciones ordinarias Clase A a un precio de ejercicio de $0 (Código M). El 05/08/25 vendió 18,206 acciones a $44.386 en una operación “sell-to-cover” para cubrir obligaciones fiscales (Código S).

Tras estas acciones, Fisher posee directamente 90,864 acciones Clase A y conserva 42,625 RSU que continúan consolidándose según el calendario original de 2023. Después de descontar la venta por impuestos, su participación directa aumentó en 24,419 acciones, lo que sugiere una alineación continua con los intereses de los accionistas. Dado que la venta fue exclusivamente para impuestos y que la mayoría de las acciones consolidadas se mantuvieron, la transacción parece rutinaria y no es probable que ejerza presión significativa sobre el flotante de SMR ni indique un cambio estratégico.

NuScale Power (SMR) 4호 서식: 최고운영책임자 Carl M. Fisher는 2025년 8월 4일에 이전에 부여된 RSU가 베스팅된 것과 관련된 내부자 거래 두 건을 보고했습니다. 8월 4일에 그는 42,625개의 제한 주식 단위(RSU)를 행사 가격 $0로 클래스 A 보통주로 전환했습니다(코드 M). 8월 5일에는 세금 원천징수 의무를 충족하기 위해 18,206주를 주당 $44.386에 매도하는 'sell-to-cover' 거래를 진행했습니다(코드 S).

이 거래 이후 Fisher는 직접 90,864주의 클래스 A 주식을 보유하고 있으며, 원래 2023년 수여 일정에 따라 계속 베스팅되는 42,625개의 RSU를 보유하고 있습니다. 세금 매도를 제외하면 그의 직접 지분은 24,419주 증가하여 주주 이익과의 지속적인 정렬을 시사합니다. 매도는 명백히 세금 납부를 위한 것이고 대부분의 베스팅 주식을 유지했기 때문에 이 거래는 일상적이며 SMR의 유통 주식 수에 큰 영향을 미치거나 전략적 변화 신호로 작용할 가능성은 낮아 보입니다.

NuScale Power (SMR) Formulaire 4 : Le directeur des opérations Carl M. Fisher a rapporté deux transactions d’initiés liées à la levée des RSU précédemment attribuées au 04/08/25. Ce jour-là, il a converti 42 625 unités d’actions restreintes en actions ordinaires de classe A à un prix d’exercice de 0 $ (Code M). Le 05/08/25, il a vendu 18 206 actions à 44,386 $ dans une opération de « sell-to-cover » pour couvrir ses obligations fiscales (Code S).

Après ces opérations, Fisher possède directement 90 864 actions de classe A et conserve 42 625 RSU qui continuent de se libérer selon le calendrier initial de la récompense 2023. Net de la vente pour impôts, sa participation directe a augmenté de 24 419 actions, ce qui suggère un alignement continu avec les intérêts des actionnaires. Comme la vente a été effectuée expressément pour les impôts et que la majorité des actions libérées ont été conservées, la transaction semble routinière et ne devrait pas exercer de pression significative sur le flottant de SMR ni indiquer un changement stratégique.

NuScale Power (SMR) Formular 4: Chief Operating Officer Carl M. Fisher meldete zwei Insider-Transaktionen im Zusammenhang mit der Vesting von zuvor gewährten RSUs am 04.08.25. An diesem Tag wandelte er 42.625 Restricted Stock Units in Class A Stammaktien zu einem Ausübungspreis von 0 $ um (Code M). Am 05.08.25 verkaufte er 18.206 Aktien zu 44,386 $ in einem „Sell-to-Cover“-Geschäft, um steuerliche Verpflichtungen zu erfüllen (Code S).

Nach diesen Transaktionen besitzt Fisher direkt 90.864 Class A Aktien und hält weiterhin 42.625 RSUs, die gemäß dem ursprünglichen Auszeichnungsplan von 2023 weiter vesten. Abzüglich des Steuerverkaufs stieg sein direkter Anteil um 24.419 Aktien, was auf eine fortlaufende Ausrichtung an den Interessen der Aktionäre hinweist. Da der Verkauf ausdrücklich zur Steuerzahlung erfolgte und der Großteil der vested Aktien behalten wurde, erscheint die Transaktion routinemäßig und wird wahrscheinlich keinen nennenswerten Druck auf den Streubesitz von SMR ausüben oder eine strategische Veränderung signalisieren.

0001729149false00017291492025-08-062025-08-06

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 6, 2025
 
Viemed Healthcare, Inc.
(Exact name of registrant as specified in its charter)
  
British Columbia, Canada
001-38973N/A
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
625 E. Kaliste Saloom Rd.
Lafayette, Louisiana
70508
(Address of principal executive offices)(Zip Code)
(337) 504-3802
(Registrant’s telephone number, including area code) 


(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common shares, no par value
VMD
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02.     Results of Operations and Financial Condition.

On August 6, 2025, Viemed Healthcare, Inc. (the "Company") issued a press release announcing its financial results for the three and six months ended June 30, 2025. The press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

In addition, the Company issued a Financial Supplement with respect to its financial results for the three and six months ended June 30, 2025. The Financial Supplement is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the foregoing information, including Exhibits 99.1 and 99.2, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and Exhibits 99.1 and 99.2 be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01.    Financial Statements and Exhibits
(d)Exhibits
 
Exhibit
Number
Description
99.1    Press Release dated August 6, 2025.
99.2    Financial Supplement dated August 6, 2025.
104     Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 6, 2025
 
VIEMED HEALTHCARE, INC.
By:
/s/ Trae Fitzgerald
Trae Fitzgerald
Chief Financial Officer
































Viemed Healthcare Inc

NASDAQ:VMD

VMD Rankings

VMD Latest News

VMD Latest SEC Filings

VMD Stock Data

249.79M
34.40M
12.97%
65.61%
1.03%
Medical Devices
Services-misc Health & Allied Services, Nec
Link
United States
LAFAYETTE